LEGAL PROCEEDINGS
−Removed: are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or
−Removed: results of operations, except as set forth below.
−Removed: There is no action, suit, proceeding, inquiry or investigation before or by
−Removed: any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive
−Removed: officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our
−Removed: subsidiaries or of our companies or our subsidiaries’
−Removed: officers or directors in their capacities as such, in which an adverse
−Removed: decision could have a material adverse effect.
+Added: April 16, 2021, a purported securities class action lawsuit, captioned David L.
+Added: was filed in the United States District Court for the Southern District of New York against the Company, Justin Schreiber (LifeMD’s
+Added: Chairman of the Board and Chief Executive Officer), Juan Pinero Dagnery (LifeMD’s former Chief Financial Officer), and Marc Benathen
+Added: (LifeMD’s current Chief Financial Officer) (the “Owens, Sr.
+Added: Lawsuit”).
+Added: The Owens, Sr.
+Added: Complaint alleges, among other
+Added: things, that the defendants made false or misleading statements about, and allegedly failed to disclose material adverse facts concerning,
+Added: the Company’s business, operations, and prospects, and asserts claims under Sections 10(b) and 20(a) of the Securities Exchange
+Added: Act of 1934 and Rule 10b-5 promulgated thereunder.
+Added: The Complaint does not quantify damages but seeks to recover damages on behalf of
+Added: investors who purchased or otherwise acquired LifeMD’s common stock between January 19, 2021 and April 13, 2021.
+Added: on May 5, 2021, a second purported securities class action lawsuit, captioned Cho v.
+Added: was filed in the United States District Court for the Southern District of New York against the same aforementioned parties (the “Cho
+Added: Lawsuit”).
+Added: The Cho Complaint makes the same claims as found in the Owens, Sr.
+Added: Lawsuit, and, similarly, does not quantify damages
+Added: and seeks to recover damages on behalf of investors who purchased or otherwise acquired LifeMD’s common stock during the same,
+Added: aforementioned time period between January 19, 2021 and April 13, 2021.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.